Forster Chase Ventures

Forster Chase Ventures is a small early-stage venture firm with a generalist or sector-specialist mandate that the public materials do not clearly disclose. The forsterchaseventures.com website and LinkedIn presence indicate an active investment vehicle, but stages, check sizes, and healthcare AI specifics are not advertised in a way founders can rely on for thesis triage. For healthcare AI founders, this is a peripheral fund best understood as potential syndicate capital rather than a lead with healthcare conviction. Plausible check sizes for small partnerships of this profile run 100K to 500K at seed and pre-seed, supporting rounds led by larger or specialized firms. Founders building horizontal AI software with healthcare applications, or healthcare-flavored B2B SaaS with strong generalist software metrics, could open a conversation. Founders building regulated medical devices, therapeutics, or clinical AI requiring deep domain expertise should look at healthcare-native firms; the absence of public healthcare focus signals that this is not the right partner for regulated work. Entry path is LinkedIn direct outreach to partners with a tight pitch focused on team, traction, and market opportunity. The website may have a contact form, but at small partnerships of this size the response rate on those is typically near zero; LinkedIn or warm introduction is the better channel. Do not expect deep healthcare-specific diligence or sector value-add; expect a generalist read on standard software metrics. If Forster Chase passes, do not over-interpret; the signal is more about thesis fit than your business. Treat any check from them as additive syndicate capital alongside a more conviction-aligned lead investor.